Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis

Study Site 332, Anniston

Study Site 363, Birmingham

Study Site 340, Hoover

Study Site 364, Glendale

Study Site 334, Cerritos

Study Site 386, Encinitas

Study Site 366, Fountain Valley

Study Site 338, Los Angeles

Study Site 383, North Hollywood

Study Site 374, Oceanside

Study Site 347, San Diego

Study Site 356, San Diego

Study Site 333, San Francisco

Study Site 376, Santa Monica

Study Site 358, Denver

Study Site 370, Jacksonville

Study Site 331, Miami

Study Site 348, Miami

Study Site 378, Miami

Study Site 353, Pinellas Park

Study Site 368, Tampa

Study Site 377, Tampa

Study Site 369, Atlanta

Study Site 349, Savannah

Study Site 381, Chicago

Study Site 360, New Albany

Study Site 380, Bardstown

Study Site 344, Louisville

Study Site 379, Boston

Study Site 350, Warren

Study Site 371, Saint Joseph

Study Site 387, Las Vegas

Study Site 352, Berlin

Study Site 375, Forest Hills

Study Site 373, Rochester

Study Site 341, High Point

Study Site 355, Shelby

Study Site 337, Oklahoma City

Study Site 345, Johnston

Study Site 362, Providence

Study Site 382, Anderson

Study Site 343, Spartanburg

Study Site 357, Chattanooga

Study Site 365, Austin

Study Site 335, Houston

Study Site 359, Pflugerville

Study Site 339, Plano

Study Site 361, San Antonio

Study Site 351, Draper

Study Site 342, Norfolk

Study Site 336, Richmond

Study Site 367, Richmond